MedTech · €150M revenue
How a MedTech provider broke up its concentration risk and opened up three new segments.
+7 %
revenue in 12 mo.
3
new segments opened up
The starting point.
From a stagnating business with concentration risk to a data-driven expansion roadmap — new markets opened up and the sales portfolio diversified.
- Concentration risk in the customer portfolio
- Stagnating business amid growing competitive pressure
- Inadequate sales targets without clear market logic
The path we walked together.
- 01
Status Quo from Three Sources
Internal and external expert interviews, competitor interviews and transaction-data analysis consolidated into a single picture.
- 02
Segment the Market
Market segmentation and in-depth competitive analysis — where is the playing field tight, and where is there room?
- 03
Prioritize the Levers
Identifying and prioritizing strategic levers per segment, brought together into an implementation roadmap.
What the new market map meant for sales.
A strategic implementation roadmap and a consolidated market map gave the sales team clear priorities — leading to 7% revenue growth within 12 months, with three newly opened segments.
+7 %
revenue in 12 mo.
3
new segments opened up
Your profitable growth starts with a conversation.
In a conversation we look at your challenges and explore which levers you can set in motion.